niflumic acid has been researched along with Neoplasms in 5 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The drug likeliness of the best compounds was also evaluated in silico to ensure the bioavailability of these compounds particularly LG1 as compared to FLU thus providing a strong rationale for their development as leads against TEAD." | 1.62 | Exploring TEAD2 as a drug target for therapeutic intervention of cancer: A multi-computational case study. ( Kumar, A; Misra, G; Pal, R, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamandis, P | 1 |
| Wildenhain, J | 1 |
| Clarke, ID | 1 |
| Sacher, AG | 1 |
| Graham, J | 1 |
| Bellows, DS | 1 |
| Ling, EK | 1 |
| Ward, RJ | 1 |
| Jamieson, LG | 1 |
| Tyers, M | 1 |
| Dirks, PB | 1 |
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Li, L | 2 |
| Zhang, M | 2 |
| Jia, D | 2 |
| Liu, Z | 2 |
| Zhang, N | 2 |
| Sun, B | 2 |
| Wang, Z | 2 |
| Liu, M | 2 |
| Wang, Q | 2 |
| Altay, A | 1 |
| Caglar, S | 1 |
| Caglar, B | 1 |
| Pal, R | 1 |
| Kumar, A | 1 |
| Misra, G | 1 |
1 review available for niflumic acid and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
4 other studies available for niflumic acid and Neoplasms
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Damage; Humans; Inflammation; Neo | 2022 |
Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Damage; Humans; Inflammation; Neo | 2022 |
Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Damage; Humans; Inflammation; Neo | 2022 |
Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; DNA Damage; Humans; Inflammation; Neo | 2022 |
Silver(I) complexes containing diclofenac and niflumic acid induce apoptosis in human-derived cancer cell lines.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diclofenac; Humans; MCF-7 C | 2022 |
Exploring TEAD2 as a drug target for therapeutic intervention of cancer: A multi-computational case study.
Topics: Binding Sites; Crystallization; DNA-Binding Proteins; Drug Discovery; Flufenamic Acid; Humans; Hydro | 2021 |